Back to search

University of British Columbia

How the infant gut microbiome shapes childhood allergic disease : data from the CHILD cohort study

Abstract

dc:description

Allergic diseases are typically characterized by a Type 2 immune response, where immune cells are sensitized to an innocuous antigen, often at a compromised epithelial barrier. Re-exposure to the antigen then leads to a pro-inflammatory response. Symptoms can include hives, airway constriction, and dizziness; when this reaction is severe, it can be life-threatening. Therefore, identifying ways to prevent allergic diseases is paramount. Studies demonstrate that microorganisms and their genes in the infant gut (known as the gut microbiome) are associated with childhood allergic diseases. This is thought to be because the expansion of the human immune system during infancy coincides with gut microbial colonization. The gut microbiome may influence epithelial barrier integrity, immune cell gene expression, and the inflammatory state of the gut, potentially priming the immune environment before sensitization. However, the underlying relationship between the gut microbiome and allergies remains unclear. Thus, I hypothesize that the early-life gut microbiome influences the development of allergic outcomes, and that by defining the structure of the early-life stool metagenome, metabolome, and mycobiome, we can predict and ultimately prevent the development of allergic disease. To test this hypothesis, I used shotgun metagenomic and internal transcribed spacer 2 (ITS2) amplicon sequencing, together with metabolomics, to identify early life gut microbiome signatures associated with allergic diseases in the large Canadian Healthy Infant Longitudinal Development (CHILD) study. I discovered that 1-year microbiota maturation was negatively associated with four distinct pediatric allergies. Specifically, a core set of functional imbalances mediated the relationship between 1-year microbiota maturation and 5-year allergic diagnoses (βindirect=−2.28; p=0.0020). Next, in investigating antibiotic-associated perturbation of the gut environment and its link to allergies, I revealed that antibiotics during the first year of life, as opposed to later, were associated with increased atopic dermatitis (AD) risk (p<0.001). Finally, fungi were reliable and consistent biomarkers of the developing gut and a persistently infant-like mycobiome was linked to childhood AD (p=0.007). In conclusion, this thesis suggests that the compositional and functional makeup of the infant gut microbiome can be used to describe microbiome development and provides insight into the associations between the microbiome and childhood allergic disease.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Microbiology and Immunology
Grantor dc:publisher
University of British Columbia
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hoskinson, Courtney
Contributors dc:contributor
  • Turvey, Stuart E.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/91268

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Hoskinson, Courtney. How the infant gut microbiome shapes childhood allergic disease : data from the CHILD cohort study. doctoral thesis, University of British Columbia, 2025. http://hdl.handle.net/2429/91268